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     Anthrax up close and personal. 
Exposure Response Guidelines 
By Cort Lohff, M.D. Assistant State Epidemiologist 
 
In the past several days, many people are reporting contact with suspicious envelopes or 
packages, and/or contact with "powders" or "substances" within these envelopes or packages. 
Given the recent events in Florida and New York, many are naturally concerned that they may 
have been exposed to anthrax.     
 
Currently, law-enforcement agencies and health departments are referring such individuals to 
health-care providers for evaluation. Following are guidelines for those performing these 
evaluations. They are based on information from the CDC, the "Consensus Statement on Anthrax 
as a Biological Weapon: Medical and Public Health Management" (JAMA 1999, Vol 281:1735-45, 
http://jama.ama-assn.org/) and our current experience with anthrax threats. See page 3. 
 
 
 
 
 
 
 
 
 
A special edition for special times 
By Director Stephen Gleason, D.O.  
 
e decided to put out a special issue of FOCUS because of intense interest in the subject of bio-
terrorism. We are receiving numerous calls and inquiries about bio-terrorism – especially 
anthrax – at the Iowa Department of Public Health, and we know you at local public health 
departments, in hospitals, clinics and physicians offices are receiving them as well.   
 
In times like these, the first duty of health-care 
professionals is preparedness. We discussed our 
efforts in that area – including public health’s part in 
the state’s emergency management plan and creation 
of our Office of Medical and Public Health Disaster 
Preparedness – in the regular October issue of 
FOCUS. Our second, almost as important, job is to 
calm the fears of our patients and the public. 
Remember, the goal of terrorists is not just to kill and 
injure, it’s to strike terror. Fear is a weapon, and it is 
effective to the extent we give in to it. So, reassure, 
hearten and calm your patients, friends, families and 
clients. See page 2. 
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(Dr. Gleason continued) There’s no inconsistency in being both alert and calm. A colleague here 
at the department compares it to putting on your seat belt before driving. We don’t expect a 
crash, and most of us aren’t anxious about driving, but with the seat belt fastened, we’re 
prepared.  
 
A whirlwind of activity has blown around anthrax in the last week. It began with media reports 
that the anthrax found at a Florida company came from Iowa. That turned out to be true only in 
the most remote sense: the strain of Florida anthrax may have originated in Iowa. It’s similar to 
saying that the chocolate bars sold in our cafeteria “came from South America,” where 
chocolate was discovered. Those reports were enough to heighten Iowans’ sense of 
vulnerability about anthrax, so we have held several news conferences and meetings to provide 
information and allay people’s fears. 
 
That same approach can be taken on the local level. Anytime you have a chance to provide 
information and calm people’s fears, either in a group situation or one-to-one, please do so. 
That will help take the wind out of the terrorists’ sails. 
 
Anthrax, by the way, is considered by the experts to be a poor choice for causing mass 
casualties. It’s very hard to make in the necessary quality and quantities and equally hard to 
distribute effectively. The effects of the limited damage in the cases discovered so far have been 
exaggerated hundreds of times over because of the public anxiety. Still, anthrax is a threat and 
as public health and health-care professionals, we can’t dismiss it. 
 
As for bio-terrorism in general, we have had meetings on biological, chemical and radiological 
terrorism for health professionals and are planning others. For specifics on these subjects, 
please see our web site, www.idph.state.ia.us. Look down the list on the right side of the page 
and click on “terrorism.” 
 
Our message echoes the consistent message from our leaders at the national and state levels: 
Prepare, but stay calm. 
 
 
 
 
 
 
 
 
 
  
Exposure Response Guidelines 
Continued from page 1. 
 
1) Assess the patient's risk of exposure to anthrax.   
Factors that can assist you in determining the patient's risk include the credibility of the 
exposure and the route of potential exposure.  Certain things associated with the package 
or envelope can assist in determining whether it contained anthrax or not.  Law enforcement 
personnel should make this determination, NOT healthcare providers.  Second, the route of 
exposure should be assessed to determine whether or not the patient would be at risk for 
cutaneous or inhalation anthrax.  To aid in this assessment, the following is provided: 
 
 • Cutaneous anthrax: The most plausible form of anthrax, it could be caused by letters or 
packages. All one needs is spores rubbed into the skin or cuts in the skin that were 
exposed to the spores.  Given its characteristic physical picture and good prognosis 
when recognized and treated, potential exposures can readily be managed by 
observation and treatment as indicated. 
 
 • Inhalation anthrax: It generally requires a large dose of fine powder - particles 1-5 
micron in size - to establish an infection.  It is technologically difficult to get anthrax into a 
form where it can be inhaled.   Reaerosolization of particles on clothing and on surfaces 
into particles of this size in nearly impossible.  Thus, visible, settled powders and letters 
or boxes that are opened and contain powders are usually not serious threats for 
inhalation anthrax.  Thus, the immediate risk to people in these situations is small.  
Inhalation anthrax would be of concern in the following circumstances: 
 
  • A person gets a face full of powder with contamination of the eyes, nose, and 
 throat; or 
  • There is a real concern of aerosolization based on a warning that an air-handling 
system is contaminated or a warning that a biological agent was released in a public 
space.  
 
2) Manage the patient based on your assessment of their risk of possible exposure. 
 
  • If no clear-cut exposure - the "worried well" (e.g., patient was visiting Florida, now 
has cold symptoms and is worried about being exposed to anthrax): Provide 
reassurance and educate about the rarity of infection without known exposure.  
  • If the only potential exposure to a powder/suspicious substance was 
cutaneous:  Provide advice to the patient on what they need to look for.  Typical 
symptoms will include itching at the site, followed by the development of a lesion that 
becomes papular, then vesicular, and in 2-6 days develops into a depressed black 
eschar, which may be surrounded by edema and/or vesicles.   
For both of the above situations, neither nasal swabs nor serological diagnosis are 
recommended.  Although nasal swabs were used by the CDC in recent investigations, 
they were used only for epidemiological purposes, NOT diagnoses.  Therefore, their use 
to determine anthrax exposure is discouraged.  
  
 
• If the situation suggests a real potential for cutaneous anthrax exposure (e.g., hand 
contact with powder or a letter in an envelope with a threatening note, etc.), provide 
assurance and counseling to the patient about the signs and symptoms of cutaneous 
anthrax and wait to start preventive treatment until cultures of the powder are 
complete.   
• If the situation suggests a real potential for inhalation anthrax exposure (e.g., got a 
face full of powder from highly suspicious situation), consider starting preventive 
therapy until exposure ruled out.  A nasal swab may be helpful in this situation to 
determine if the patient was exposed, if the powder or other substance was not 
available for testing.  Again, this is for exposure determination, not diagnosis. 
 
If you feel that the patient needs prophylaxis, please call the Iowa Department of Public Health, 
Center for Acute Disease Epidemiology at 1-800-362-2736 for further guidance.  During 
business hours, someone will answer directly.  After hours, you will be prompted to call the 
State Patrol, who will in turn, page someone on call. 
 
Please remember that law-enforcement personnel should make the determination of the 
credibility of the threat of exposure, not health-care providers.  Health-care providers may need 
to consult with the law enforcement personnel handling the case or with the local or state health 
department when they assess the patient. 
 
Additional information can be found at the department's website, www.idph.state.ia.us. Select 
terrorism.  
  
 
At top, Cutaneous anthrax. At right, 
Inhalation anthrax. 
  
 
Helping kids cope with a less trustful world 
By  Edward Schor, M.D. 
Medical Director of Family & Community Health 
 
he terrorism of Sept. 11, vividly presented in the media, created upsetting images in the 
minds of children.  The distress that children experienced, reinforced by more recent 
events, is likely to continue for some time.  Children, like adults, are feeling that their lives 
are not as secure as they had been and they feel less trustful of the world. 
 
Children’s reactions are determined by how serious the trauma was that they experienced or 
observed, by how secure they feel within their home and family, and by their age or 
development.  Young children, five and under, may be fearful and diffusely anxious.  They may 
have a fear of separating from their parents and be more prone to crying or tantrums.  Children 
may return to behaviors they had earlier, thumb-sucking, bed-wetting, and fear of darkness.  
Young children are especially sensitive to their parents’ reactions to these events. 
 
School-age children, and to a lesser degree adolescents, may become withdrawn and avoid 
discussing the things that upset them.  At the extreme, they may not want to leave the house or 
attend school.  They may have trouble paying attention at home and at school, and school work 
can suffer.  This aged child also may have problems sleeping and bodily symptoms such as 
headaches or stomach aches that have no apparent medical basis.  Like younger children, 
school-age children and youth can become anxious or may exhibit signs of sadness and 
depression.  Preadolescents and adolescents may wonder, “What kind of world am I growing up 
in?  Will I ever feel safe again?” 
 
As they interact with their young children, parents should try to limit the amount of exposure 
children have to upsetting media coverage.  For all children, it has been suggested that parents 
follow three core principles, the 3-R’s of Reassurance, Routine, and Ritual. 
 
Reassurance:  Parents should talk about their own feelings, but as calmly as possible.  
Children’s questions should be answered simply and directly, but without going beyond 
addressing what was asked or beyond the child’s developmental capacity to understand.  
Encourage children to express their feelings, but don’t try to force them to talk.  Let children 
know that you will do everything possible to keep them and the other members of their family 
safe. 
 
Routine:  Children gain great comfort from routines.  Try to maintain your regular household 
schedule, keeping mealtime, homework time, and bedtime about the same as usual.  Playtime 
may be especially important.  Not only does exercise reduce stress, having the opportunity to 
explore and express their feelings through play is very therapeutic. 
 
Ritual:  Try to counter the memories of traumatic events by providing opportunities to respond 
actively and positively.  Attend a worship service or a community activity that addresses the 
T
  
New "terrorism" link on IDPH web site 
 
Find up-to-date information on the IDPH web site at www.idph.state.ia.us. Look for the 
"terrorism" link at right on the home page. There are further links to press releases, fact 
sheets, frequently asked questions, telephone numbers and more.  
 
traumatic events.  Participate in fund-raising or relief efforts, or write to victims’ families or 
rescuers to express thanks. 
 
For more information, visit: http://www.nimh.nih.gov 
 
 
 
 
 
 
 
 
 
Use anthrax medication wisely 
Provided by the Iowa Pharmacy Association 
 
ue to the recent threat of bioterrorism, many people have started to obtain the medication 
Cipro (ciprofloxacin) in case of an anthrax exposure.  Some people are obtaining this 
medication through sources that bypass the normal prescriber/patient relationship.  
 
Cipro should not be taken without a health-care provider’s supervision, and should not be 
obtained from anyone but a health-care professional.  Cipro has many side effects, including 
common reactions such as nausea, vomiting, diarrhea, abdominal pain, headache, rash, and 
restlessness.  It also has some less common but severe adverse reactions such as seizures, 
allergic reactions, and tendon rupture.  In addition, extensive use of Cipro can lead to increased 
antibiotic-resistant bacteria.  
 
According to the CDC and the Bayer Corp, the manufacturer, Cipro should be taken as 400mg 
IV q12 hours or 500mg po bid for 60 days for Anthrax exposure. Many web sites offer Cipro as a 
3- or 7-day supply. This leads to the belief that people who are obtaining this medication from 
these sites are probably not going take it for the recommended length of time; therefore, it will 
be ineffective as a prophylaxis treatment. 
 
There are many drug interactions with Cipro.  Below is a list of these medications.  Some are 
potentially severe and underscore the need for supervision of a health-care provider. 
 
Antacids – When taken 2 hours before or 6 hours after, they may decrease Cipro’s efficacy due 
to decreased absorption. 
 
Calcium salts – When taken 2 hours before or 6 hours after, they may decrease Cipro’s 
efficacy due to decreased absorption. 
 
D
  
Cyclosporine – May increase cyclosporine levels leading to a risk of toxicity; may also cause a 
transient increase in serum creatinine levels. 
 
Didanosine – When taken 2 hours before or 6 hours after, it may decrease Cipro’s efficacy due 
to decreased absorption. 
 
Glyburide – May increase risk of hypoglycemia.  
 
Glyburide/metformin – May increase risk of hypoglycemia iron salts. When taken 2 hours 
before or 6 hours after, they may decrease Cipro’s efficacy due to decreased absorption. 
 
NSAIDs – May increase risk of CNS stimulation and seizures.  
 
Oral contraceptives – Ciprofloxacin may decrease the effectiveness of oral contraceptives. 
 
Phenytoin – May increase or decrease phenytoin levels by altering the hepatic metabolism of 
phenytoin. 
 
Probenecid - May increase quinolone levels leading to a risk of toxicity due to a decrease in 
renal excretion. 
 
Sucralfate – When taken 2 hours before or 6 hours after, it may decrease Cipro’s efficacy due 
to decreased absorption. 
 
Theophylline – May increase theophylline levels by elevating serum concentrations and 
prolonging the elimination half-life leading to a risk of toxicity by inhibiting hepatic metabolism. 
 
Warfarin – Increased risk of bleeding and increased INR due to inhibition of hepatic metabolism 
and altered vitamin K production by the gut flora. 
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